Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5385-5389

  Hashemi, Farnaz Amouzegar ^a   Akbari, Ehsan Hamed ^a   Kalaghchi, Bita ^a   Esmati, Ebrahim ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer; Gemcitabine; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COBALT; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COBALT RADIOISOTOPES; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84887602359     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5385     Document Type: Article

References (23)

1. Aghili M, Andalib B, Amouzegar Hashemi F, et al (2010).Concurrent chemo-brachytherapy with cisplatin and intracavitary brachytherapy in locally advanced uterine cervical cancer basic. Clin Cancer Res, 2, 45-52.
2. Alvarez AM, Mickiewicz E, Roth B, et al (2001). Feasibility of accelerated radiotherapy (RT) concurrent with low dose biweekly gemcitabine (G) and cisplatin (C) in locally advanced cervical carcinoma (LACC). Proc Am Soc Clin Oncol, 20, 2150.
3. Alvarez AM, Mickiewicz E, Rodger J, et al (2002). Radiotherapy (RT) with low dose biweekly gemcitabine (LDBG) and cisplatin in locally advanced cervical carcinoma (LACC): (stages IIa-IVa). Proc Am Soc Clin Oncol, 21, 892.
4. Amouzegar Hashemi F, Zahedi F, Farhan F, et al (2009).Medium dose rate brachytherapy for patients with cervical carcinoma; early results of a prospective trial. Tehran Uni Med J, 66, 888-93.
5. Brunner T, Grabenbauer G, Kastl S, et al (2000). A phase I trial of simultaneous gemcitabine (GEM)/cisplatin (CDDP) and radiotherapy (RT) for patients (PTS) with locally advanced pancreatic adenocarcinoma (PAC). Proc Am Soc Clin Oncol, 19, 284.
6. Brunner TB, Grabennauer GG, Klein P, et al (2003). Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Int J Rad Oncol, 551, 144-53.
7. Duenas-Gonzales A, Cetina L, Mariscal I, et al (2003). Modern management of locally advanced cervical carcinoma. Cancer Treat Rev, 29, 389-99.
8. Duenaz-Gonzalez A, Zarba JJ, Patel F, et al (2011). Phase III, open-label, randomized study comparing concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplstin and radiation inpatients with stage IIB to IV carcinoma of cervix. J Clinical Oncol, 29, 1678.
9. Eifel PF, Berek JS, Thigpen JT (2001). Cancer of the cervix, vagina, and vulva, VT DeVita, S Hellman, SA Rosenberg, Editors, Cancer, principles and practice of oncology, (6th ed.), Lippincott Raven Publishers, Philadelphia, pp 1526-73.
10. Goedhals L, Bezwoda WR (1996). A phase II study of gemcitabine in advanced cervix carcinoma: final data. Proc Am Soc Clin Oncol, 15, 296.
11. Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics. CA Cancer J Clin, 531, 5-26.
12. Kanzawa F, Saijo N (1997). In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model. Semin Oncol, 24, 7-16.
13. Lawrence TS, Eisbruch A, Shewach DS (1997). Gemcitabine-mediated radiosensitization. Semin Oncol, 24, 7-28.
14. McCormack M, Thomas H (2000). A phase Ib study of gemcitabine and concurrent radiotherapy in carcinoma of the cervix. Ann Oncol, 11, 396.
15. Mohideen M, McCall A, Kamradt R (1997). Activity of gemcitabine and its radiosensitization of human cervical cancer cells. Proc Am Soc Clin Oncol, 17, 245.
16. Mousavi A, Karimi Zarchi M, Gilani MM, et al (2008). Radical hysterectomy in the elderly. World J surg Oncol, 6, 38.
17. Okusaka T, Ito Y, Ueno H, et al (2004). Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. Br J Cancer, 914, 673-7.
18. Petersson F (1998). Carcinoma of the cervix. In annual report on the results of treatments in gynecological cancer. Stockholm, Sweden: International Federation of Gynecology and Obstetrics, 29-33.
19. Peters WA, Liu PY, Barrett RJ, et al (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol, 18, 1606-13.
20. Porras AR, Valencia N, Bastarrachea J (2003). Weekly gemcitabine concurrently to external radiotherapy for cervical cancer stages Ib2-IVa. Proc Am Soc Clin Oncol, 22, 1987.
21. Siegel R, Ward E, Brawley O, Lemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA cancer J Clin, 61, 212.
22. Van Putten JW, Price A, van der Leest AH, et al (2003). A phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. Clin Cancer Res, 97, 2472-7.
23. Zarba JJ, Jaremtchuk AV, GonzalezJazey P, et al (2003). A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Ann Oncol, 148, 1285-90.